SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: chirodoc who wrote (1054)11/14/1998 12:55:00 PM
From: Anthony Wong  Respond to of 1722
 
curtis, I agree that one doesn't have the same of degree of confidence on Searle's ability to get drugs through FDA approval, but I would assume that Pfizer, having a lot at stake on this drug and having paid $140 million (?) upfront to MTC for the marketing rights (and spending another $100 million on hiring salespeople), would be closely monitoring and advising Searle on this matter.

We both have PFE+MTC, so good luck to both of us.

Anthony



To: chirodoc who wrote (1054)11/15/1998 8:03:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 1722
 
American Home Products May Make Bid for Monsanto, Forbes Says

Bloomberg News
November 15, 1998, 6:36 p.m. ET

New York, Nov. 15 (Bloomberg) -- American Home Products may
again be eyeing Monsanto, barely one month after the two canceled
their proposed $35 billion merger, Forbes reported in its
''Streetwalker'' column. American Home's Chief Executive Officer
John Stafford has gotten a closer look at Monsanto's pipeline and
likes what he sees and is planning to launch an unfriendly bid
that would, among other things, dump Monsanto Chief Executive
Officer Robert Shapiro. The original deal would have had American
Home Products buying Monsanto for stock and winding up with
65 percent control of the company, Forbes said.

St. Louis-based Monsanto and Madison, New Jersey-based
American Home Products canceled their merger Oct. 14, after
company executives, analysts said, could not agree on who would
control the company.

(Forbes 11/30 365 www.forbes.com



To: chirodoc who wrote (1054)11/16/1998 1:00:00 PM
From: Anthony Wong  Read Replies (3) | Respond to of 1722
 
Monsanto Co. Maintained 'Recommend List' at Goldman Sachs

Bloomberg News
November 16, 1998, 11:43 a.m. ET

Princeton, New Jersey, Nov. 16 (Bloomberg Data) -- Monsanto Co. (MTC US)
was maintained ''recommend list'' by analyst Avi Nash at Goldman, Sachs & Co.